imatinib mesylate has been researched along with Atherosclerotic Parkinsonism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; He, Q; Huang, Q; Li, M; Liu, Q; Ma, J; Wu, R; Yuan, Z | 1 |
1 other study(ies) available for imatinib mesylate and Atherosclerotic Parkinsonism
Article | Year |
---|---|
c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Sequence; Animals; Cell Death; Dopaminergic Neurons; Enzyme Activation; Female; HEK293 Cells; Humans; Imatinib Mesylate; Male; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Molecular Sequence Data; Oxidative Stress; Parkinson Disease, Secondary; Phosphorylation; Protein Binding; Protein Interaction Maps; Protein Multimerization; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-abl; Signal Transduction | 2016 |